IceCure Medical (ICCM) Profit After Tax (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Profit After Tax data on file, last reported at -$4.3 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at -$4.3 million, down 219.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (up 146.91% YoY), and the FY2025 annual result was $15.1 million, up 198.3% from the prior year.
• Profit After Tax declined to -$4.3 million in Q1 2026 per ICCM's latest filing, from $4.2 million in the prior quarter.
• Over five years, Profit After Tax peaked at $4.2 million in Q4 2025 and troughed at -$26.2 million in Q4 2024.
• A 5-year average of -$2.1 million and a median of -$3.8 million in 2023 frame the typical range for Profit After Tax.
• On a YoY basis, Profit After Tax climbed as much as 203.72% in 2024 and fell as far as 773.36% in 2024.
• A 5-year view of Profit After Tax shows it stood at -$4.0 million in 2022, then advanced by 24.22% to -$3.0 million in 2023, then tumbled by 773.36% to -$26.2 million in 2024, then surged by 116.23% to $4.2 million in 2025, then tumbled by 200.66% to -$4.3 million in 2026.
• Business Quant data shows ICCM's Profit After Tax at -$4.3 million in Q1 2026, $4.2 million in Q4 2025, and $3.9 million in Q3 2025.